Rose Sharon Shabet serves as Executive at BridgeBio Pharma, Inc., where they oversee executive responsibilities. Since joining the company, Rose Sharon Shabet has executed 15 insider transactions totaling $128.1M, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 19, 2023 involved exercising options for 2,609,392 shares valued at $0.
Rose Sharon Shabet currently holds 3,968,588 shares of BridgeBio Pharma, Inc. (BBIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rose Sharon Shabet has been a net buyer of BBIO stock. They have purchased $118.8M and sold $9.4M worth of shares.
Rose Sharon Shabet's most recent insider trade was on Sep 19, 2023, when they sold 2,609,392 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Sep 19, 2023 | RYZB | $16.8M | Purchase | 930,556 | $18.00 | Discretionary |
| Sep 19, 2023 | RYZB | $8.2M | Purchase | 458,333 | $18.00 | Discretionary |
| Sep 19, 2023 | RYZB | $0 | Conversion | 494,687 | $N/A | Discretionary |
| Sep 19, 2023 | RYZB | $0 | Conversion | 864,509 | $N/A | Discretionary |
| May 9, 2023 | FDMT | $13.6M | Purchase | 850,000 | $16.00 | Discretionary |
| Sep 3, 2021 | FIGS | $1.9M | Sale | 42,413 | $44.92 | Discretionary |
| Sep 2, 2021 | FIGS | $7.5M | Sale | 157,587 | $47.28 | Discretionary |
| Jun 27, 2019 | BBIO | $0 | Conversion | 11,736,137 | $N/A | Discretionary |
| Jun 27, 2019 | BBIO | $80.0M | Purchase | 4,705,900 | $17.00 | Discretionary |
| Jun 27, 2019 | BBIO | $0 | Conversion | 10,178,954 | $N/A | Discretionary |
| Jun 14, 2019 | UROV | $56.5K | Purchase | 7,144 | $7.91 | Discretionary |
| Jun 13, 2019 | UROV | $58.6K | Purchase | 7,367 | $7.95 | Discretionary |
| Jun 12, 2019 | UROV | $62.3K | Purchase | 7,500 | $8.30 | Discretionary |